|
AGPAT3 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.902090E-03 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.697400E-03 |
| Normal-vs-AfricanAmerican |
7.859000E-03 |
| Normal-vs-Asian |
1.560450E-02 |
| Caucasian-vs-AfricanAmerican |
7.614000E-01 |
| Caucasian-vs-Asian |
6.733200E-01 |
| AfricanAmerican-vs-Asian |
5.582600E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.095700E-03 |
| Normal-vs-Female |
4.568800E-04 |
| Male-vs-Female |
9.103400E-03 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.960000E-04 |
| Normal-vs-Age(41-60Yrs) |
4.402700E-03 |
| Normal-vs-Age(61-80Yrs) |
6.157300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.089000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.037800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.716400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.642590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.986000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.803200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.274200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
6.435900E-03 |
| Normal-vs-Pheochromocytoma |
2.837800E-03 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.503530E-03 |
| Paraganglioma-vs-Pheochromocytoma |
9.343400E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.737400E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.960750E-01 |
|
|
